MedPath

Renal artery nerve interruption guided by location and electrical stimulatio

Conditions
Essential hypertension
Registration Number
NL-OMON23038
Lead Sponsor
VU medical center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Other
Sex
Not specified
Target Recruitment
20
Inclusion Criteria

Essential hypertension

- Three antihypertensive drugs, of which one a diuretic

Exclusion Criteria

- Age > 65 y

- Ambulantory blood pressure > 180/110 mmHg in the absence of antihypertensive medication

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
- to study blood pressure changes in response to electrical stimulation pre- and post-ablation
Secondary Outcome Measures
NameTimeMethod
- to study the effect of renal denervation on renal blood flow as expressed by renal flow reserve and resistance index. <br>- to study the effect of renal denervation on office- and ambulatory blood pressure. <br /><br>- to study the effect of renal denervation on the efferent sympathetic nervous system activity as expressed by catecholamine levels and natriuresis. <br /><br>- to study the effect of RDN on central sympathetic nervous activity as expressed by heart rate variability and peripheral arterial tonometry. <br>
© Copyright 2025. All Rights Reserved by MedPath